Advertisement

Molecular Medicine

, Volume 15, Issue 1–2, pp 60–63 | Cite as

Educational and Social-Ethical Issues in the Pursuit of Molecular Medicine

  • Panagiotis A. Konstantinopoulos
  • Michalis V. Karamouzis
  • Athanasios G. Papavassiliou
Mini-Review

Abstract

Molecular medicine is transforming everyday clinical practice from an empirical art to a rational ortho-molecular science. The prevailing concept in this emerging framework of molecular medicine is a personalized approach to disease prevention, diagnosis, prognosis, and treatment. In this mini-review, we discuss the educational and social-ethical issues raised by the advances of biomedical research as related to medical practice; outline the implications of molecular medicine for patients, physicians, and researchers; and underline the responsibilities of academia and the pharmaceutical industry to translate the scientific knowledge to a meaningful improvement of the quality of life across all members of society.

References

  1. 1.
    Papavassiliou AG. (2001) Clinical practice in the new era. A fusion of molecular biology and classical medicine is transforming the way we look at and treat diseases. EMBO Rep. 2:80–2.CrossRefGoogle Scholar
  2. 2.
    Link E, et al. (2008) SLCO1B1 variants and statin-induced myopathy—a genomewide study. N. Engl. J. Med. 359:789–99.CrossRefGoogle Scholar
  3. 3.
    Kaelin WG, Jr. (2005) The concept of synthetic lethality in the context of anticancer therapy. Nat. Rev. Cancer 5:689–98.PubMedGoogle Scholar
  4. 4.
    Sharma SV, Bell DW, Settleman J, Haber DA. (2007) Epidermal growth factor receptor mutations in lung cancer. Nat. Rev. Cancer 7:169–81.CrossRefGoogle Scholar
  5. 5.
    Quackenbush J. (2006) Microarray analysis and tumor classification. N. Engl. J. Med. 354:2463–72.CrossRefGoogle Scholar
  6. 6.
    Paik S, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351:2817–26.CrossRefGoogle Scholar
  7. 7.
    Konstantinopoulos PA, Spentzos D, Cannistra SA. (2008) Gene-expression profiling in epithelial ovarian cancer. Nat. Clin. Pract. Oncol. 5:577–87.CrossRefGoogle Scholar
  8. 8.
    Jones S, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801–6.CrossRefGoogle Scholar
  9. 9.
    Parsons DW, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–12.CrossRefGoogle Scholar
  10. 10.
    Whitney SN, et al. (2008) Principal investigator views of the IRB system. Int. J. Med. Sci. 5:68–72.Google Scholar
  11. 11.
    Breckenridge A, et al. (2004) Pharmacogenetics: ethical problems and solutions. Nat. Rev. Genet. 5:676–80.Google Scholar
  12. 12.
    Nathan D, Benz EJ. (2001) Comprehensive cancer centres and the war on cancer. Nat. Rev. Cancer 1:240–5.CrossRefGoogle Scholar
  13. 13.
    Nathan DG. (2002) Careers in translational clinical research-historical perspectives, future challenges. JAMA 287:2424–7.CrossRefGoogle Scholar
  14. 14.
    Schwartz P, Gaulton GN. (1999) Addressing the needs of basic and clinical research: analysis of graduates of the University of Pennsylvania MD-PhD program. JAMA 281:96–7.CrossRefGoogle Scholar
  15. 15.
    Smith HC, Hundert EM. (1999) Integrating molecular medicine into the medical school curriculum. Mol. Med. Today 5:102–3.CrossRefGoogle Scholar
  16. 16.
    Fornai F, et al. (2008) Lithium delays progression of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 105:2052–7.CrossRefGoogle Scholar

Copyright information

© The Feinstein Institute for Medical Research 2009

Authors and Affiliations

  • Panagiotis A. Konstantinopoulos
    • 1
    • 2
  • Michalis V. Karamouzis
    • 1
  • Athanasios G. Papavassiliou
    • 1
  1. 1.Department of Biological ChemistryUniversity of Athens Medical SchoolAthensGreece
  2. 2.Division of Hematology-OncologyBeth Israel Deaconess Medical Center, Harvard Medical SchoolBostonUSA

Personalised recommendations